# PHASE_2_P61 Report

## 1. Phase Identifier
`PHASE_2_P61_FC_VAE_CONTROLLED_STEP_COUNT_EXPANSION_AUDIT_NO_DATASET_NO_GENERALIZATION`

## 2. Goal
Add a controlled step-count expansion audit for the accepted FC-VAE bounded micro-training path, comparing deterministic runs with 5, 10, and 20 SGD steps on the same three P50 bridge targets, without changing the objective, introducing datasets, dataloaders, generalization claims, generation claims, or scientific claims.

## 3. Base Branch/Head
- **Base Branch:** `phase2/p60-fc-vae-target-balance-objective-audit-no-training-change-no-dataset`
- **Base Head Commit:** `7dcd90d7cf3510979b911eddeeef1fbcd843aa04`

## 4. Changed Files
| File | Status | Description |
|------|--------|-------------|
| `src/phase2/fc_vae_controlled_step_count_expansion_audit.py` | NEW | Code executing deterministic step-count expansion runs and cross-run comparison |
| `tools/phase2/run_p61_fc_vae_controlled_step_count_expansion_audit_smoke.py` | NEW | Command-line smoke script running the audit and printing compact JSON |
| `tests/test_phase2_fc_vae_controlled_step_count_expansion_audit.py` | NEW | Focused unit tests for P61 |
| `tests/test_phase2_p61_fc_vae_controlled_step_count_expansion_audit_smoke.py` | NEW | Smoke integration tests |
| `reports/PHASE_2_P61_FC_VAE_CONTROLLED_STEP_COUNT_EXPANSION_AUDIT_NO_DATASET_NO_GENERALIZATION_REPORT.md` | NEW | This report |

## 5. Why P61 is Controlled Step-Count Audit Only
P61 is strictly diagnostic. It runs controlled deterministic steps (5, 10, and 20 SGD steps) using the existing bridge targets, fixed seed, and uniform objective. It does not introduce actual dataset training, dataloaders, optimizer changes, or model changes.

## 6. Deterministic Setup
- **Target Count:** `3`
- **Target IDs:** `["bridge_lambda_0_25", "bridge_lambda_0_5", "bridge_lambda_0_75"]`
- **Optimizer:** `SGD`
- **Learning Rate:** `1e-4`
- **Beta:** `0.001`
- **Seed:** `61061`
- **Eps Mode:** `"zero"`

## 7. Step-Count Contract
P61 runs three distinct loops of `range(step_count)` with `step_count` in `[5, 10, 20]`. Each loop is completely independent, initialized from a freshly built model using manual seed `61061`.

## 8. 5-step Run Diagnostics
- Initial Loss / Final Objective Loss: `1.05648` $\rightarrow$ `1.01794`
- Final Reconstruction Mean: `1.01777`
- Final KL Mean: `0.17135`
- Parameter Change: `true` (32/32 changed)
- Group Delta Pass: `true` (decoder, encoder_trunk, posterior heads changed)
- All Targets Improved: `true` (absolute total improvements: 0.25: `0.03116`, 0.5: `0.03834`, 0.75: `0.04611`)

## 9. 10-step Run Diagnostics
- Initial Loss / Final Objective Loss: `1.05648` $\rightarrow$ `0.98593`
- Final Reconstruction Mean: `0.98575`
- Final KL Mean: `0.17148`
- Parameter Change: `true` (32/32 changed)
- Group Delta Pass: `true`
- All Targets Improved: `true` (absolute total improvements: 0.25: `0.05739`, 0.5: `0.06990`, 0.75: `0.08436`)

## 10. 20-step Run Diagnostics
- Initial Loss / Final Objective Loss: `1.05648` $\rightarrow$ `0.93922`
- Final Reconstruction Mean: `0.93902`
- Final KL Mean: `0.17163`
- Parameter Change: `true` (32/32 changed)
- Group Delta Pass: `true`
- All Targets Improved: `true` (absolute total improvements: 0.25: `0.09886`, 0.5: `0.11718`, 0.75: `0.13880`)

## 11. Cross-Run Objective Comparison
- **Final Objectives:**
  - 5 Steps: `1.01794`
  - 10 Steps: `0.98593`
  - 20 Steps: `0.93922`
- **Objective Deltas:**
  - 10 vs 5: `-0.03201`
  - 20 vs 5: `-0.07872`
  - 20 vs 10: `-0.04671`
- **Monotonicity:**
  - `10 <= 5`: `true`
  - `20 <= 10`: `true`
  - `20 <= 5`: `true`

Extending the step count consistently decreases the objective value.

## 12. Cross-Run Reconstruction/KL Comparison
- **Final Reconstruction Means:**
  - 5 Steps: `1.01777`
  - 10 Steps: `0.98575`
  - 20 Steps: `0.93902`
- **Final KL Means:**
  - 5 Steps: `0.17135`
  - 10 Steps: `0.17148`
  - 20 Steps: `0.17163`
- **KL Growth Ratio (20 vs 5):** `1.00164`

Reconstruction losses decrease monotonically, and the KL divergence grows marginally (by only `+0.16%`), demonstrating high stability in the encoder/posterior mapping.

## 13. Per-Target Improvement Matrix
| Target ID | Improvement @ 5 | Improvement @ 10 | Improvement @ 20 | Nondecreasing |
|---|---|---|---|---|
| `bridge_lambda_0_25` | `0.03116` | `0.05739` | `0.09886` | `true` |
| `bridge_lambda_0_5` | `0.03834` | `0.06990` | `0.11718` | `true` |
| `bridge_lambda_0_75` | `0.04611` | `0.08436` | `0.13880` | `true` |

All targets show nondecreasing improvement as the step count increases.

## 14. Dominance Stability Across Step Counts
- **Dominant Target Shares:**
  - 5 Steps: `43.90%` (dominant target: `bridge_lambda_0_75`)
  - 10 Steps: `44.03%` (dominant target: `bridge_lambda_0_75`)
  - 20 Steps: `44.22%` (dominant target: `bridge_lambda_0_75`)
- Max dominant share across runs: `44.22%`
- Dominance warning across runs (`share >= 40%`): `true`
- Dominance blocker across runs (`share >= 50%`): `false`

The hard target (`bridge_lambda_0_75`) triggers the 40% warning threshold but remains well below the 50% dominance blocker.

## 15. Explosion/Blocker Diagnostics
- **Objective Explosion Ratio (20 vs 5):** `0.92267` (Blocker threshold = `1.25`)
- **Objective Explosion Blocker Triggered:** `false`
- **KL Explosion Blocker Triggered:** `false` (growth ratio `1.00164` < `1.25`)
- **Dominance Blocker Across Runs Triggered:** `false`

## 16. Uniform Objective Preservation
- `no_weighted_training = true`
- `uniform_objective_preserved = true`

## 17. No Dataset/No Generalization Boundary
The boundary constraints are fully satisfied:
- `no_dataset = true`
- `no_dataloader = true`
- `no_epoch_loop = true`
- `no_batch_loop = true`
- `no_scheduler = true`
- `no_checkpointing = true`
- `no_generalization_claim = true`
- `no_generation_claim = true`
- `no_gsb_claim = true`
- `no_scientific_conclusion = true`
- `no_latent_learning_claim = true`
- `no_vae_success_claim = true`
- `no_convergence_claim = true`
- `no_semantic_geometry_proof_claim = true`

## 18. Smoke Output
```json
{"all_runs_passed":true,"beta":0.001,"contract_version":"phase2_p61_fc_vae_controlled_step_count_expansion_audit_contract_v1","cross_run_comparison":{"all_runs_passed":true,"all_targets_improved_at_all_step_counts":true,"baseline_final_objective_value":1.0179396867752075,"cross_run_passed":true,"delta_10_vs_5":-0.03201037645339966,"delta_20_vs_5":-0.078715980052948,"delta_20_vs_10":-0.04670560359954834,"dominance_blocker_across_runs":false,"dominance_final_share":{"steps_10":0.4402636224177579,"steps_20":0.4422206775435948,"steps_5":0.43901947169123107},"dominance_share_max_across_runs":0.4422206775435948,"dominance_warning_across_runs":true,"final_kl_mean_comparison":{"steps_10":0.17147770524024963,"steps_20":0.17162875831127167,"steps_5":0.17134733498096466},"final_reconstruction_mean_comparison":{"steps_10":0.9857547283172607,"steps_20":0.9390197992324829,"steps_5":1.017768383026123},"is_10_less_equal_5":true,"is_20_less_equal_10":true,"is_20_less_equal_5":true,"kl_explosion_blocker_triggered":false,"kl_growth_ratio_20_vs_5":1.0016421949111494,"objective_explosion_blocker_triggered":false,"objective_explosion_ratio_20_vs_5":0.9226713483986061,"per_target_improvement_matrix":[{"improvement_at_10":0.05738872289657593,"improvement_at_20":0.09885871410369873,"improvement_at_5":0.03116166591644287,"nondecreasing_improvement":true,"target_id":"bridge_lambda_0_25"},{"improvement_at_10":0.06990432739257812,"improvement_at_20":0.11717885732650757,"improvement_at_5":0.038343608379364014,"nondecreasing_improvement":true,"target_id":"bridge_lambda_0_5"},{"improvement_at_10":0.08436107635498047,"improvement_at_20":0.13880455493927002,"improvement_at_5":0.04611086845397949,"nondecreasing_improvement":true,"target_id":"bridge_lambda_0_75"}],"uniform_objective_stable_across_step_counts":true},"cross_run_passed":true,"eps_mode":"zero","kind":"fc_vae_controlled_step_count_expansion_audit_no_dataset_no_generalization","learning_rate":0.0001,"no_batch_loop":true,"no_checkpointing":true,"no_convergence_claim":true,"no_dataloader":true,"no_dataset":true,"no_epoch_loop":true,"no_generalization_claim":true,"no_generation_claim":true,"no_gsb_claim":true,"no_latent_learning_claim":true,"no_scheduler":true,"no_scientific_conclusion":true,"no_semantic_geometry_proof_claim":true,"no_weighted_training":true,"optimizer_name":"SGD","realizability_claim":"controlled_step_count_expansion_audit_only_no_dataset_no_generalization","reason":"fc_vae_controlled_step_count_expansion_audit_probe_success","run_summaries":{"steps_10":{...},"steps_20":{...},"steps_5":{...}},"seed_value":61061,"source_phase":"P61","status":"fc_vae_controlled_step_count_expansion_audit_available_no_dataset_no_generalization","step_counts":[5,10,20],"target_count":3,"target_ids":["bridge_lambda_0_25","bridge_lambda_0_5","bridge_lambda_0_75"],"torch_available":true,"uniform_objective_preserved":true,"verdict":"PASS"}
```

## 19. Focused Tests
`python -m pytest tests/test_phase2_fc_vae_controlled_step_count_expansion_audit.py tests/test_phase2_p61_fc_vae_controlled_step_count_expansion_audit_smoke.py -v`
- **Result:** `20 passed`

## 20. Full Curated Tests
- **Result:** `3054 passed, 40 skipped, 0 failed` ✅

## 21. Scope Gate
The P61 scope gate enforces that only the allowed P61 files are created relative to the P60 base head (`7dcd90d7cf3510979b911eddeeef1fbcd843aa04`).

## 22. Remaining Blockers
None.

## 23. Final Verdict
`P61_READY_FOR_REVIEW`

“P61 validates a controlled 5/10/20-step expansion audit for the uniform FC-VAE objective without introducing datasets, weighted training, or generalization claims.”
